Abstract
The COVID-19 pandemic has precipitated a global crisis, with more than 690,000 confirmed cases and more than 33,000 confirmed deaths globally as of March 30, 2020 [1–4]. At present two central public health control strategies have emerged: mitigation and suppression (e.g, [5]). Both strategies focus on reducing new infections by reducing interactions (and both raise questions of sustainability and long-term tactics). Complementary to those approaches, here we develop and analyze an epidemiological intervention model that leverages serological tests [6, 7] to identify and deploy recovered individuals as focal points for sustaining safer interactions via interaction substitution, i.e., to develop what we term ‘shield immunity’ at the population scale. Recovered individuals, in the present context, represent those who have developed protective, antibodies to SARS-CoV-2 and are no longer shedding virus [8]. The objective of a shield immunity strategy is to help sustain the interactions necessary for the functioning of essential goods and services (including but not limited to tending to the elderly [9], hospital care, schools, and food supply) while decreasing the probability of transmission during such essential interactions. We show that a shield immunity approach may significantly reduce the length and reduce the overall burden of an outbreak, and can work synergistically with social distancing. The present model highlights the value of serological testing as part of intervention strategies, in addition to its well recognized roles in estimating prevalence [10, 11] and in the potential development of plasma-based therapies [12–15].
Publisher
Cold Spring Harbor Laboratory
Reference37 articles.
1. Fauci, A. S. , Lane, H. C. & Redfield, R. R. Covid-19 – navigating the uncharted. New England Journal of Medicine (2020). URL https://doi.org/10.1056/NEJMe2002387.
2. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
3. Zhou, P. et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 270–273 (2020).
4. World Health Organization: Coronavirus disease 2019 (COVID-19) Situation Report - 70 (2020). URL https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid-19.pdf?sfvrsn=7e0fe3f8_2.
5. Ferguson, N. et al.. Impact of non-pharmaceutical interventions (npis) to reduce COVID19 mortality and healthcare demand (2020). URL https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-{COVID19}-NPI-modelling-16-03-2020.pdf.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献